Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medical Journals Need Taste Of Their Own Medicine, FDA’s Gottlieb Says

Executive Summary

Medical journals need to take measures to expedite providing up-to-date information to physicians, FDA Deputy Commissioner for Scientific & Regulatory Affairs Scott Gottlieb said

You may also be interested in...

VIGORous Debate Continues In NEJM Over Propriety Of Merck’s Vioxx Study

Merck's Vioxx VIGOR trial results do not need to be corrected, authors of the study assert in letters to the editors of the New England Journal of Medicine Feb. 22

FDA Advisory Committees Need Better Conflict Of Interest Procedures – NEJM

FDA should publish the names and background information of proposed advisory committee members in advance of scheduled meetings, a New England Journal of Medicine editorial recommends

Clinical Trial Registry Policy Will Be Flexible For Phase II, Journal Editors Say

Medical journal editors will apply a case-by-case analysis in determining whether to publish data from Phase II studies that have not been listed in public clinical trial registries, the International Committee of Medical Journal Editors said as the July 1 deadline for trial registration approaches




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts